Galderma online survey reveals essential COVID-19 mask wearing can be worsening rosacea skin disease
PR88143
LAUSANNE, Switzerland, Feb. 19, 2021 /PRNewswire=KYODO JBN/ --
- Although essential for public health, new online survey findings show that
people with self-reported rosacea* may be experiencing worsening of symptoms
due to mask wearing, further increasing the daily burden for people living with
this chronic skin disease
- Despite worsening of signs and symptoms, only a third (33%) of respondents
have visited a healthcare provider (HCP) in person since the pandemic began
The COVID-19 pandemic has made mask wearing commonplace in many parts of the
world, but for those suffering with facial skin disease, this can bring
additional challenges. A recent survey conducted by Galderma suggests that the
pandemic may impact rosacea patients, from worsening of signs and symptoms
related to mask wearing, to reduced HCP consultations.[1]
Although essential for public health, findings from the new online survey
involving 220 respondents* from Canada and Germany reveal that almost two
thirds (63%) are experiencing worsening of their symptoms related to mask
wearing, including redness (75%), pimples and/or pustules (72%) and more
flare-ups (53%).[1]
A recent independent clinical study in Italy, investigating the impact of mask
wearing in rosacea and acne vulgaris patients, also found that prolonged use of
face masks increases disease severity and significantly impacts the quality of
life of rosacea and acne patients.[2]
Despite worsening of symptoms, over 1 in 2 (52%) people surveyed* admitted
using mask wearing as a way to hide their disease, and 40% are not going out as
often in order to avoid wearing a mask. The survey also revealed that almost a
third (30%) are spending more time on their skincare routine during the
pandemic.
Additionally, nearly half (48%) have changed how they manage their disease
since mask wearing, with 51% trying a non-prescription product and only 27%
having been prescribed a new treatment by a HCP.[1]
Aliene Noda, Global Medical Franchise Lead Rosacea and Onco-Dermatology
Prescription GBU, Galderma, comments on these findings: "With just a third of
rosacea sufferers surveyed booking an appointment with their HCP during the
pandemic, there is a huge cause for concern. Our survey suggests that more
patients may be self-treating which could mean they are using products that are
not specifically tailored for their skin disease and this could, ultimately, do
more harm than good."
Prof. Dr Jerry Tan, Adjunct Professor, Western University, Ontario, Canada,
says: "During the current pandemic, self-medication and inadequate use of
prescribed rosacea treatments are concerning. Many rosacea sufferers are hiding
their rosacea under a mask to reduce embarrassment. This could however also be
worsening their rosacea. If you are suffering from rosacea, do not be afraid to
book an appointment with your HCP via phone, video or in-person if possible. It
is important to adhere to prescribed treatments and seek professional support
if you are experiencing worsening of signs and symptoms because of mask
wearing."
The survey shows that only a third (33%) of respondents have visited their HCP
in person since the pandemic began, with only 8% having a video consultation.
Of those who have not booked an appointment, 47% stated they have not wanted to
book an appointment, whilst 21% have been unable to book one.[1]
*Based on a self-administered survey of www.FaceUpToRosacea.com and
www.stelldichdeinerrosacea.de email subscribers during December 2020 – January
2021. 87% of whom state that they have a rosacea diagnosis from a healthcare
provider. 13% believe that they have rosacea but are not yet diagnosed
References:
1. Data on file. Online survey of faceuptorosacea.com and
stelldichdeinerrosacea.de https://www.stelldichdeinerrosacea.de/email
subscribers (220 respondents from Canada and Germany)
2. Damiani G, et al. Dermatol Ther. 2021 Feb. DOI: 10.1111/dth.14848. [Epub
ahead of print].
About rosacea
Rosacea is a common inflammatory skin disease that presents variable clinical
characteristics, of which the most common are flushing, persistent erythema,
and inflammatory lesions. It mainly affects the central areas of the face, such
as the cheeks and nose. The disease can affect both adult men and women,
usually after the age of 30. Additionally, symptoms such as stinging, burning
and increased sensitivity of the skin are common. The eyes are often affected,
and might present as red, dry or itchy.
Although the cause of the disease is still under debate, various trigger
factors are known, including spicy foods, alcohol, emotional stress,
sun/UV-exposure, hot baths and beverages. Demodex, generally harmless mites,
can also be found in the skin in an elevated quantity in people with rosacea.
Rosacea may worsen over time if left untreated. People that suspect they suffer
from rosacea should visit their dermatologist or healthcare provider for
diagnosis and discuss what treatment is right for them. Because rosacea is a
highly visible disease, it is known to cause embarrassment and anxiety in some
patients, which in turn may cause frustration and have a negative impact on
their social life.
About Galderma
Galderma, the world's largest independent global dermatology company, was
created in 1981 and is now present in over 100 countries with an extensive
product portfolio of prescription medicines, aesthetic solutions and consumer
care products. The company partners with health care practitioners around the
world to meet the skin health needs of people throughout their lifetime.
Galderma is a leader in research and development of scientifically-defined and
medically-proven solutions for the skin. For more information, please visit
www.galderma.com.
(C) 2021 Galderma S.A. All Right Reserved. All trademarks are the property of
their respective owners
Source: Galderma
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。